Does CETUXIMAB Cause Neoplasm malignant? 14 Reports in FDA Database
Boost Your Natural Energy & Metabolism
Mitolyn — 6 exotic plants to unlock your body's fat-burning power. 90-day guarantee.
According to the FDA Adverse Event Reporting System (FAERS), 14 reports of Neoplasm malignant have been filed in association with CETUXIMAB (ERBITUX). This represents 0.1% of all adverse event reports for CETUXIMAB.
14
Reports of Neoplasm malignant with CETUXIMAB
0.1%
of all CETUXIMAB reports
4
Deaths
4
Hospitalizations
How Dangerous Is Neoplasm malignant From CETUXIMAB?
Of the 14 reports, 4 (28.6%) resulted in death, 4 (28.6%) required hospitalization.
Is Neoplasm malignant Listed in the Official Label?
This adverse event is not currently listed in the official FDA drug label for CETUXIMAB. However, 14 reports have been filed with the FAERS database.
What Other Side Effects Does CETUXIMAB Cause?
Off label use (1,549)
Rash (883)
Diarrhoea (874)
Neutropenia (744)
Nausea (663)
Malignant neoplasm progression (662)
Dyspnoea (542)
Decreased appetite (541)
Vomiting (533)
Death (518)
What Other Drugs Cause Neoplasm malignant?
RANITIDINE (10,648)
ADALIMUMAB (2,028)
APIXABAN (1,772)
ETANERCEPT (1,616)
METHOTREXATE (1,041)
TOFACITINIB (1,020)
RITUXIMAB (929)
INFLIXIMAB (892)
ABATACEPT (727)
RISANKIZUMAB-RZAA (715)
Which CETUXIMAB Alternatives Have Lower Neoplasm malignant Risk?
CETUXIMAB vs CETYLPYRIDINIUM
CETUXIMAB vs CEVIMELINE
CETUXIMAB vs CHAMPIX
CETUXIMAB vs CHANTIX
CETUXIMAB vs CHENODIOL